Davidson Kempner Capital Management LP

Position in ACLX — Arcellx, Inc.

CIK 1595082 New York, NY

Position in ACLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$64,258,324

New position

Shares Held

559,644

first reported quarter

Ownership

0.957%

of shares outstanding

% of Portfolio

2.56%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Davidson Kempner Capital Management LP holds $88,015,790 across 5 Biotechnology names. ACLX ranks #1 (73.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc. This page	559,644	$64,258,324
2	TERN	Terns Pharmaceuticals, Inc.	311,623	$16,428,764
3	CBUS	Cibus, Inc.	1,527,606	$3,024,659
4	RVMD	Revolution Medicines, Inc.	27,075	$2,633,043
5	KPTI	Karyopharm Therapeutics Inc.	300,000	$1,671,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$64,258,324	559,644	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.